Efficacy News and Research

RSS
Are overactive immune cells causing COVID-19-related deaths?

Are overactive immune cells causing COVID-19-related deaths?

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

Scripps Research establishes collaborative global effort to rapidly find drugs against COVID-19

Drug improves effectiveness of chemotherapy in ovarian cancer patients

Drug improves effectiveness of chemotherapy in ovarian cancer patients

Remdesivir drug stops novel coronavirus from replicating

Remdesivir drug stops novel coronavirus from replicating

New drug preserves cognitive function in mice after brain irradiation

New drug preserves cognitive function in mice after brain irradiation

Chronic stress can influence the efficacy of radiation therapy, study suggests

Chronic stress can influence the efficacy of radiation therapy, study suggests

The race is on for a coronavirus vaccine, 70 candidates, 3 at human trial stage

The race is on for a coronavirus vaccine, 70 candidates, 3 at human trial stage

New vaccine for Chikungunya reported safe and well-tolerated

New vaccine for Chikungunya reported safe and well-tolerated

Cost of ‘repurposing’ existing drugs to treat COVID-19

Cost of ‘repurposing’ existing drugs to treat COVID-19

Missing COVID-19 antibodies suggest mystery immune response

Missing COVID-19 antibodies suggest mystery immune response

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Rockefeller and SNF announce $3 million expansion of partnership for COVID-19 research

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

People with type 2 diabetes and heart disease may benefit from newer therapies

Remdesivir shows promise in post-infection treatment for COVID-19 disease

Remdesivir shows promise in post-infection treatment for COVID-19 disease

Little to lose - time for everyone to wear face masks for COVID-19

Little to lose - time for everyone to wear face masks for COVID-19

Promising COVID-19 drug treatments identified with new screening strategies

Promising COVID-19 drug treatments identified with new screening strategies

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

UofL researchers use computers in schools across Kentucky to identify drugs for COVID-19

UofL researchers use computers in schools across Kentucky to identify drugs for COVID-19

New €4.5 million collaborative project to develop cold plasma therapies for orthopedic infection

New €4.5 million collaborative project to develop cold plasma therapies for orthopedic infection

Researchers identify COVID-19 drug lead treatments

Researchers identify COVID-19 drug lead treatments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.